Nicolaas Schipper

Rise, Z, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Corrigendum to "Sustained intravitreal dissolution and kinase inhibition by an inhibitory cGMP analogue after its injection as a suspension of a poorly soluble salt" [Biomed. Pharmacother. 199 (2026) 119387].

Corrigendum to "Sustained intravitreal dissolution and kinase inhibition by an inhibitory cGMP analogue after its injection as a suspension of a poorly soluble salt" [Biomed. Pharmacother. 199 (2026) 119387].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 02, 2026

Sustained intravitreal dissolution and kinase inhibition by an inhibitory cGMP analogue after its injection as a suspension of a poorly soluble salt.

Sustained intravitreal dissolution and kinase inhibition by an inhibitory cGMP analogue after its injection as a suspension of a poorly soluble salt.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 02, 2026

Advancing Safe and Sustainable by Design Practices in Pharmaceutical Manufacturing: The PHARMECO Project.

Advancing Safe and Sustainable by Design Practices in Pharmaceutical Manufacturing: The PHARMECO Project.

Journal: ChemSusChem

Published: June 11, 2025

Drug release and pharmacokinetics of intravitreal liposomal injections: a case study with cyclic guanosine monophosphate derivative.

Drug release and pharmacokinetics of intravitreal liposomal injections: a case study with cyclic guanosine monophosphate derivative.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: February 12, 2025

New Improved cGMP Analogues to Target Rod Photoreceptor Degeneration.

New Improved cGMP Analogues to Target Rod Photoreceptor Degeneration.

Journal: Journal of medicinal chemistry

Published: April 30, 2024

Crystal Modifications of a Cyclic Guanosine Phosphorothioate Analogue, a Drug Candidate for Retinal Neurodegenerations.

Crystal Modifications of a Cyclic Guanosine Phosphorothioate Analogue, a Drug Candidate for Retinal Neurodegenerations.

Journal: ChemistryOpen

Published: August 17, 2023

Pyruvate-conjugation of PEGylated liposomes for targeted drug delivery to retinal photoreceptors.

Pyruvate-conjugation of PEGylated liposomes for targeted drug delivery to retinal photoreceptors.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 16, 2023

Ocular permeability, intraocular biodistribution of lipid nanocapsule formulation intended for retinal drug delivery.

Ocular permeability, intraocular biodistribution of lipid nanocapsule formulation intended for retinal drug delivery.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: January 31, 2023

Structural Characterization Study of a Lipid Nanocapsule Formulation Intended for Drug Delivery Applications Using Small-Angle Scattering Techniques.

Structural Characterization Study of a Lipid Nanocapsule Formulation Intended for Drug Delivery Applications Using Small-Angle Scattering Techniques.

Journal: Molecular pharmaceutics

Published: February 28, 2022

Efficient Delivery of Hydrophilic Small Molecules to Retinal Cell Lines Using Gel Core-Containing Solid Lipid Nanoparticles.

Efficient Delivery of Hydrophilic Small Molecules to Retinal Cell Lines Using Gel Core-Containing Solid Lipid Nanoparticles.

Journal: Pharmaceutics

Published: November 19, 2021

Preparative Synthesis of an R P-Guanosine-3',5'-Cyclic Phosphorothioate Analogue, a Drug Candidate for the Treatment of Retinal Degenerations.

Preparative Synthesis of an R P-Guanosine-3',5'-Cyclic Phosphorothioate Analogue, a Drug Candidate for the Treatment of Retinal Degenerations.

Journal: Organic process research & development

Published: June 17, 2021

Investigating Ex Vivo Animal Models to Test the Performance of Intravitreal Liposomal Drug Delivery Systems.

Investigating Ex Vivo Animal Models to Test the Performance of Intravitreal Liposomal Drug Delivery Systems.

Journal: Pharmaceutics

Published: May 31, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026